CNNM4

Across TCGA pan-cancer cohorts, CNNM4 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CNNM4 data layer compared with 25 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in small cell lung cancer (SCLC), where higher CNNM4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CNNM4 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

SCLC, LUSC, and SARC are the cancer types where CNNM4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Median	All	0.082	0.708	<.001	36	view →
LUSC	DFS	Median	All	0.079	0.792	<.001	23	view →
SARC	DFS	Median	All	0.179	0.612	.024	6	view →
UCEC	DFS	Median	All	0.909	0.609	.018	4	view →
SKCM	DFS	Median	II,III,IV	0.237	0.594	.025	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CNNM4–SCLC (OS)

Open the SCLC breakdown →